Published in Vaccine on October 01, 1988
Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect Immun (1995) 1.29
Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun (1998) 1.05
Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria. Clin Diagn Lab Immunol (1999) 0.80
Animal Enterotoxigenic Escherichia coli. Ecosal Plus (2016) 0.75
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med (1992) 5.51
Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol (1998) 5.12
Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14
The tolC locus of Escherichia coli affects the expression of three major outer membrane proteins. J Bacteriol (1982) 3.51
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell (1989) 3.08
Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci U S A (1992) 3.00
The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol (1986) 2.48
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med (1989) 2.45
Shotgun optical maps of the whole Escherichia coli O157:H7 genome. Genome Res (2001) 2.43
Escherichia coli K-12 outer membrane protein (OmpA) as a bacteriophage receptor: analysis of mutant genes expressing altered proteins. J Bacteriol (1984) 2.37
Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in streptococcus pneumoniae. Mol Microbiol (2000) 2.34
The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol (1997) 2.33
Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infect Immun (1994) 2.24
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat Med (2000) 2.22
Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc Natl Acad Sci U S A (1995) 2.15
Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway. Mol Microbiol (1997) 2.11
Salmonella enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells. Infect Immun (2000) 2.04
Identification and characterization of the TolC protein, an outer membrane protein from Escherichia coli. J Bacteriol (1983) 2.00
A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun (1988) 1.86
Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene (1991) 1.84
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73
Mediation of serum resistance in Salmonella typhimurium by an 11-kilodalton polypeptide encoded by the cryptic plasmid. J Infect Dis (1987) 1.70
A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr Biol (1999) 1.70
Primary structure of the tolC gene that codes for an outer membrane protein of Escherichia coli K12. Nucleic Acids Res (1983) 1.65
Mechanism of bacteriophage SfII-mediated serotype conversion in Shigella flexneri. Mol Microbiol (1997) 1.65
Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19. J Bacteriol (1999) 1.61
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet (1993) 1.59
Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett (1999) 1.57
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun (1990) 1.55
Regulation of the pho regulon of Escherichia coli K-12. Cloning of the regulatory genes phoB and phoR and identification of their gene products. J Mol Biol (1982) 1.55
Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.54
A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb Pathog (1988) 1.54
Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck. J Clin Invest (1992) 1.50
The colonization of Peyer's patches by a strain of Salmonella typhimurium cured of the cryptic plasmid. J Infect Dis (1986) 1.49
Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol (1986) 1.48
Characterization of the dTDP-rhamnose biosynthetic genes encoded in the rfb locus of Shigella flexneri. Mol Microbiol (1994) 1.48
Isolation, characterization, and nucleotide sequence of IS1202, an insertion sequence of Streptococcus pneumoniae. J Bacteriol (1994) 1.48
Regulation of O-antigen chain length is required for Shigella flexneri virulence. Mol Microbiol (1997) 1.47
Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 19B. J Bacteriol (1997) 1.47
Overexpression and topology of the Shigella flexneri O-antigen polymerase (Rfc/Wzy). Mol Microbiol (1998) 1.46
Molecular cloning, characterization, and nucleotide sequence of the rfc gene, which encodes an O-antigen polymerase of Salmonella typhimurium. J Bacteriol (1991) 1.46
Pterygium in Australia: a cost of illness study. Clin Experiment Ophthalmol (2001) 1.40
Construction of defined galE mutants of Salmonella for use as vaccines. J Infect Dis (1987) 1.37
Analysis of Shigella flexneri wzz (Rol) function by mutagenesis and cross-linking: wzz is able to oligomerize. Mol Microbiol (1999) 1.36
The Salmonella typhi melittin resistance gene pqaB affects intracellular growth in PMA-differentiated U937 cells, polymyxin B resistance and lipopolysaccharide. Microbiology (1999) 1.35
Molecular cloning, nucleotide sequence, and function of a site-specific recombinase encoded in the major 'pathogenicity island' of Salmonella typhi. Gene (1997) 1.34
Analysis of the 5' portion of the type 19A capsule locus identifies two classes of cpsC, cpsD, and cpsE genes in Streptococcus pneumoniae. J Bacteriol (1999) 1.32
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma. J Clin Oncol (2003) 1.32
Molecular cloning of the tolC locus of Escherichia coli K-12 with the use of transposon Tn10. Mol Gen Genet (1981) 1.29
Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol Rev (1998) 1.28
Murine natural killer cells do not express functional transcripts of the alpha-, beta-, or gamma-chain genes of the T cell receptor. J Immunol (1986) 1.28
Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect Immun (1991) 1.27
A putative pathway for perosamine biosynthesis is the first function encoded within the rfb region of Vibrio cholerae O1. Gene (1995) 1.27
Bacteriophage receptor area of outer membrane protein OmpA of Escherichia coli K-12. J Bacteriol (1985) 1.26
Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health. Minerva Pediatr (2007) 1.22
PhoP/Q regulated genes in Salmonella typhi identification of melittin sensitive mutants. Microb Pathog (1997) 1.21
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose. Infect Immun (2001) 1.20
Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J Gen Virol (1993) 1.19
Genetic analysis of the rfb region of Shigella flexneri encoding the Y serotype O-antigen specificity. Mol Microbiol (1991) 1.18
RB and the cell cycle: entrance or exit? Cell (1989) 1.18
Molecular analysis of the Enterobacter sakazakii O-antigen gene locus. Appl Environ Microbiol (2008) 1.17
Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 23F. Microbiology (1999) 1.16
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J Immunother Emphasis Tumor Immunol (1994) 1.16
The TolC protein of Escherichia coli K12 is synthesised in a precursor form. FEBS Lett (1983) 1.15
Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol (2001) 1.13
Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene (1995) 1.12
Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. J Med Genet (1993) 1.08
Genetic analysis of the rfbX gene of Shigella flexneri. Gene (1995) 1.08
Growth factor induction by the adenovirus type 5 E1A 12S protein is required for immortalization of primary epithelial cells. Mol Cell Biol (1988) 1.07
Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene (1997) 1.04
Application of pulsed-field gel electrophoresis to characterise and trace the prevalence of Enterobacter sakazakii in an infant formula processing facility. Int J Food Microbiol (2007) 1.03
Comparison of disc diffusion and epsilometer (E-test) testing techniques to determine antimicrobial susceptibility of Campylobacter isolates of food and human clinical origin. J Microbiol Methods (2009) 1.03
A hypermutable insert in an immunoglobulin transgene contains hotspots of somatic mutation and sequences predicting highly stable structures in the RNA transcript. J Exp Med (1998) 1.02
Phosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2). J Biol Chem (2001) 1.02
Molecular aspects of somatic hypermutation of immunoglobulin genes. Cold Spring Harb Symp Quant Biol (1999) 1.02
Women who decline antenatal screening for HIV infection in the era of universal testing: results of an audit of uptake in three London hospitals. J Public Health (Oxf) (2005) 1.01
Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. J Virol Methods (2000) 1.01
Tracking verocytotoxigenic Escherichia coli O157, O26, O111, O103 and O145 in Irish cattle. Int J Food Microbiol (2011) 1.01
Fuchs' corneal dystrophy. A clinicopathologic study of the variation in corneal edema. Ophthalmology (1986) 1.00
Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microb Pathog (1990) 1.00
Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor. J Immunol (1985) 1.00
A physical map of the chromosomal region determining O-antigen biosynthesis in Vibrio cholerae O1. Gene (1987) 1.00
Inhibition of immunoglobulin gene rearrangement by the expression of a lambda 2 transgene. J Exp Med (1989) 0.99
Campylobacter spp. in Irish feedlot cattle: a longitudinal study involving pre-harvest and harvest phases of the food chain. J Vet Med B Infect Dis Vet Public Health (2004) 0.99
Host range mutants of bacteriophage Ox2 can use two different outer membrane proteins of Escherichia coli K-12 as receptors. J Bacteriol (1984) 0.98
The parVP region of the Salmonella typhimurium virulence plasmid pSLT contains four loci required for incompatibility and partition. Plasmid (1993) 0.96
Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma (1989) 0.96
Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci (1981) 0.95